The roof of Carnegie Vanguard High School features an example of the Green Stormwater Infrastructure. Photo courtesy of the City of Houston

The City of Houston has launched a pilot project that will speed up the permitting process for environmentally friendly stormwater projects.

The Green Stormwater Infrastructure Expedited Permitting Pilot Program, announced August 4, will approve at least 10 projects in the Houston area by August 2022. In conjunction with the Resilient Houston initiative, the city is targeting 100 green stormwater infrastructure projects by 2025.

The city is working on rules and regulations that will govern development of green stormwater infrastructure. Mayor Sylvester Turner rolled out a tax abatement program for green stormwater infrastructure projects last December.

According to a city news release, green stormwater infrastructure improves the performance of drainage systems and can make real estate projects more attractive to buyers, while delivering benefits such as heat reduction, improvement of air and water quality, and conservation of native habitats.

Green stormwater infrastructure helps reduce the downstream impact of development and mimics how rain behaves when it falls onto an undeveloped green landscape. Techniques that fit into this category include green roofs, rain gardens, rainwater harvesting, permeable pavement, and urban forests.

"In the aftermath of Hurricane Harvey, we have taken critical steps to address our flooding and drainage challenges. As Houston has rapidly developed, we have relied on traditional gray infrastructure systems to keep us safe. However, as we build forward, we must consider new and innovative approaches for achieving greater flood resilience in Houston," the city says in a 2019 report about green stormwater infrastructure.

Traditional "gray" infrastructure, designed to move urban stormwater away from the built environment, includes curbs, gutters, drains, piping, and collection systems, according to the U.S. Environmental Protection Agency (EPA). Generally, gray infrastructure collects and moves stormwater from impervious surfaces, such as roadways, parking lots, and rooftops, and into a series of pipes that ultimately send untreated stormwater into local waterways.

In tandem with Houston's new permitting program, the city has created the Green Stormwater Infrastructure Awards and Recognition Program. The program salutes green development and redevelopment projects. It "is intended to recognize some of the most effective and exemplary of 'green' building in Houston and encourage more development projects to adopt resilient measures," according to the news release.

Projects considered for the awards program will be judged on factors such as:

  • Proximity to nearby communities.
  • Impact on nearby communities.
  • Efforts to conserve native plants.

Turner says the permitting and awards programs are part of an initiative aimed at "futureproofing our city" to ease harm caused by hurricanes and flooding.

"In Houston and in towns across the U.S., climate change is no longer knocking on our front door; it's broken into the house," Turner wrote in an opinion piece published in July by The Hill.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”